Table 3.
Characteristics of the samples from the original cohort and new samples including histology and stage (FIGO), used in the ELISA confirmation and validation of SELDI-TOF MS results
| Benign | Stage I | Stage II | Stage III | Malignant | |
|---|---|---|---|---|---|
| Original cohort: |
n = 20: |
n = 12: |
n = 0: |
n = 8: |
n = 20: |
| New samples |
n = 20 |
n = 7 |
n = 1 |
n = 12 |
n = 20 |
|
Simple |
4:6 |
|
|
|
|
|
Stromal |
1:1 |
|
|
|
|
|
Endometrioma |
2:1 |
|
|
|
|
|
Serous |
8:8 |
6:2 |
0:1 |
6:11 |
12:14 |
|
Mucinous |
5:4 |
3:1 |
|
1:0 |
4:1 |
|
Endometrioid |
|
2:2 |
|
|
2:2 |
|
Clear cell |
|
1:2 |
|
1:0 |
2:2 |
| Undifferentiated | 0:1 | 0:1 |